Predictive Oncology Inc. Common Stock (POAI)
Predictive Oncology Inc. (POAI) is a biotechnology company specializing in using artificial intelligence and data analytics to develop personalized cancer treatments. The company focuses on leveraging genomic and clinical data to identify targeted therapies, aiming to improve outcomes for cancer patients through tailored medicine solutions.
Company News
Predictive Oncology and Every Cure are collaborating to use AI platforms for identifying and repurposing existing drugs for cancer treatments, leveraging their respective AI technologies and extensive biobanks to accelerate drug discovery and improve patient outcomes.
Renovaro Inc. has received a ruling to expedite a trial in 2025 for a lawsuit it filed against Predictive Oncology Inc., seeking to enforce a binding merger agreement executed on January 1, 2025. Renovaro alleges that Predictive Oncology breached the agreement's exclusivity and good faith negotiation provisions.
A lawsuit filed in Delaware last week against travel site Tripadvisor and its majority shareholder is highlighting what may be a growing trend.
Penny stocks under $1 to watch before next week. The post Penny Stocks To Buy? 4 Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?